Tissue-engineered skin in the healing of wound stumps from limb amputations secondary to purpura fulminans

Pediatric Dermatology

Volumn 20, Issue 2, 2003, Pages 169-172

  Greenberg, J E ^a   Falabella, A F ^a   Bello, Y M ^a   Schachner, Lawrence A ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PSEUDOMONIC ACID;

ANALGESIA; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; FEMALE; FULMINATING PURPURA; HUMAN; INFANT; LIMB AMPUTATION; MENINGOCOCCEMIA; PRIORITY JOURNAL; SKIN NECROSIS; SKIN ULCER; SPLIT THICKNESS SKIN GRAFT; TISSUE ENGINEERING; WOUND CARE; WOUND HEALING;

AMPUTATION; AMPUTATION STUMPS; CASE REPORT; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMAN; INFANT; LOWER EXTREMITY; NECROSIS; PURPURA, SCHOENLEIN-HENOCH; RISK ASSESSMENT; SKIN TRANSPLANTATION; SKIN, ARTIFICIAL; TISSUE ENGINEERING; WOUND HEALING;

EID: 0037361425     PISSN: 07368046     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1470.2003.20218.x     Document Type: Article

References (24)

1. Marks MI. Bacterial meningitis - an update. Clin Pediatr 1991;30:673-675.
2. Sheridan RL, Briggs SE, Remensnyder JP, Tompkins RG. Management strategy in purpura fulminans with multiple organ failure in children. Burns 1996;22:53-56.
3. Adendorf DJ, Lamont A, Davies D. Skin loss in meningococcal septicemia. Br J Plast Surg 1980;33:251-255.
4. Schaller RT, Schaller JF. Surgical management of life threatening and disfiguring sequelae of fulminant meningococcemia. Am J Surg 1986;151:553-556.
5. Genoff MC, Hoffer MM, Achauer B, Formosa P. Extremity amputations in meningococcemia-induced purpura fulminans. Plast Reconstr Surg 1992;89:878-881.
6. Silbart S, Oppenheim W. Purpura fulminans. Medical, surgical, and rehabilitative considerations. Clin Orthop 1985;193:206-213.
7. Nagi J. Physeal arrest in purpura fulminans: a report of three cases. J Bone Joint Surg Am 1989;71:929-931.
8. Redett RJ, Bury TF, McClinton MA. The use of simultaneous free latissimus dorsi tissue transfers for reconstruction of bilateral upper extremities in a case of purpura fulminans. J Hand Surg Am 2000;25:559-564.
9. Horn WA. Graftskin heals an ulcer on an amputation stump. Dermatol Surg 2000;26:946-948.
10. Riberti C, Parodi PC, Osti M, Longhi P, Vaienti L, Azzolini C. Myofasciocutaneous expansion in the tegumentary rehabilitation of the amputation stump. Chir Organi Mov 1998;83:291-297.
11. Sheridan RL, Briggs SE, Remensnyder JP, et al. The burn unit as a resource for the management of acute nonburn conditions in children. J Burn Care Rehab 1995;16:62-64.
12. Hulard O, Toledano E, Zalta R, Legre R, Magalon G. [Use of "foot-bank" tissue to cover amputation stumps. Apropos of 4 cases]. Rev Chir Orthop Reparatrice Appar Mot 1997;83:673-676.
13. Hulard O, Voinchet V, Bardot J, Legre R, Magalon G. [Use of skin expansion in resurfacing defective amputation stumps of the lower limbs. 6 case reports]. Rev Chir Orthop Reparatrice Appar Mot 1999;85:512-516.
14. Manise O, Watier E, Rostane-Renouard D, Staerman H, Pailheret JP. [Use of tissue expansion on defective amputation stumps of the lower limbs. Apropos of 5 cases]. Ann Chir Plast Esthet 1996;41:155-160.
15. Besner GE, Klamar JE. Integra artificial skin a useful adjunct in the treatment of purpura fulminans. J Burn Care Rehab 1998;19:324-329.
16. Waisman D, Shupak A, Weisz G, Melamed Y. Hyperbaric oxygen therapy in the pediatric patient: the experience of the Israel Naval Medical Institute. Pediatrics 1998; 102:E53.
17. Falabella AF, Valencia IC, Eaglstein WH, Schachner LS. Tissue-engineered skin (Apligraf) in the healing of patients with epidermolysis bullosa wounds. Arch Dermatol 2000; 136:1225-1230.
18. Eaglstein WH, Falanga V. Tissue engineering and the development of Apligraf, a human skin equivalent. Adv Wound Care J Prev Healing 1998;11:1-8.
19. Falanga V, Margolis D, Alvarez O, et al. Rapid healing of venous leg ulcers and lack of clinical rejection with an allogenic cultured human skin equivalent. Arch Dermatol 1998;134:293-300.
20. Veves A, Falanga V, Armstrong DG, Sabolinkski ML. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers. Diabetes Care 2001;24:290-295.
21. Eaglstein WH, Alvarez OM, Auletta M, et al. Acute excisional wounds treated with a tissue engineered skin (Apligraf). Dermatol Surg 1999;25:195-201.
22. Muhart M, McFalls S, Kirsner RS, et al. Behavior of tissue-engineered skin: a comparison of a living skin equivalent, autograft, and occlusive dressing in human donor sites [see comments]. Arch Dermatol 1999;135:913-918.
23. Navsaria HA, Myers SR, Leigh IM, et al. Culturing skin in vitro for wound therapy. Trends Biotechnol 1995;13:91-99.
24. Trent JF, Kirsner RS. Tissue engineered skin: Apligraf, a bi-layered living skin equivalent. Int J Clin Pract 1998;52:407-413.